Christopher Schelling

Christopher Schelling is the founder of Censa Pharmaceuticals, Inc. (founded in 2015), Acer Therapeutics, Inc. (founded in 2017), and Apanii Consulting LLC (founded in 2012).
He held the titles of Secretary, Director & Head-Operations at Censa Pharmaceuticals, Inc. and President, Chief Executive Officer & Director at Acer Therapeutics, Inc. Mr. Schelling's current job is Director at Cascade Prodrug, Inc. where he started in 2017.
Mr. Schelling's former jobs include President, Chief Executive Officer & Director at Opexa Therapeutics, Inc. and Executive Director-Strategic Marketing at BioMarin Pharmaceutical, Inc. where he worked from 2006 to 2012.
Mr. Schelling received his undergraduate degree from Carroll College (Montana).
Mr. Schelling is also the founder of Acer Therapeutics, Inc.